國際肝病協(xié)會的宗旨是促進(jìn)肝病科學(xué)從基礎(chǔ)研究到臨床應(yīng)用研究的各個方面的發(fā)展。它是一份國際期刊，為發(fā)表高質(zhì)量的肝病原創(chuàng)性研究提供了一個論壇。它為所有關(guān)注肝臟及其組成細(xì)胞的正常和異常結(jié)構(gòu)和功能的專業(yè)人員提供了必要的資源，旨在為臨床醫(yī)生和涉及肝臟多學(xué)科領(lǐng)域的基礎(chǔ)科學(xué)家服務(wù)。它包括從實驗?zāi)Ｐ秃腿梭w材料的病理生物學(xué)研究。國際肝病歡迎來自肝病學(xué)各個領(lǐng)域的文章，這些文章可以作為原創(chuàng)文章、快速交流、評論和給編輯的信件發(fā)表。如果對臨床問題進(jìn)行詳細(xì)研究并在更廣泛的背景下引起足夠的興趣，病例報告將被接受。論文通常由至少兩名獨(dú)立審稿人參與的同行評審過程進(jìn)行評估。在期刊范圍內(nèi)，文章將被接受的基礎(chǔ)上，科學(xué)的質(zhì)量，獨(dú)創(chuàng)性和最新的相關(guān)性。

The general aim of Liver International is to promote all aspects of the science of hepatology from basic research to applied clinical studies. It is an international Journal providing a forum for the publication of high quality original research in hepatology. It provides an essential resource for all professionals concerned with normal and abnormal structure and function in the liver and its constituent cells and is intended for clinicians and basic scientists involved in the multi-disciplinary field of hepatology. It includes studies of pathobiology from experimental models and human material. Liver International welcomes articles from all fields of hepatology, which may be published as original articles, rapid communications, reviews, and letters to the Editor. Case reports will be accepted if the clinical problem is studied in detail and of sufficient interest in a wider context. Papers are normally evaluated by a peer review process involving at least two independent reviewers. Within the scope of the Journal, articles will be accepted on the basis of scientific quality, originality and up-to-date relevance.